Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse.

Identifieur interne : 002C77 ( PubMed/Curation ); précédent : 002C76; suivant : 002C78

Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse.

Auteurs : Leonora E. Long [Australie] ; Paul Anderson [Australie] ; Elisabeth Frank [Australie] ; Alex Shaw [Australie] ; Shijie Liu [Australie] ; Xu-Feng Huang [Australie] ; Didier Pinault [France] ; Tim Karl [Australie] ; Terence J. O'Brien [Australie] ; Cynthia Shannon Weickert [Australie] ; Nigel C. Jones [Australie]

Source :

RBID : pubmed:25992564

Descripteurs français

English descriptors

Abstract

The Neuregulin 1 transmembrane domain heterozygous mutant (Nrg1 TM HET) mouse is used to investigate the role of Nrg1 in brain function and schizophrenia-like behavioural phenotypes. However, the molecular alterations in brain Nrg1 expression that underpin the behavioural observations have been assumed, but not directly determined. Here we comprehensively characterise mRNA Nrg1 transcripts throughout development of the Nrg1 TM HET mouse. In addition, we investigate the regulation of high-frequency (gamma) electrophysiological oscillations in this mutant mouse to associate molecular changes in Nrg1 with a schizophrenia-relevant neurophysiological profile.

DOI: 10.1371/journal.pone.0124114
PubMed: 25992564

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:25992564

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse.</title>
<author>
<name sortKey="Long, Leonora E" sort="Long, Leonora E" uniqKey="Long L" first="Leonora E" last="Long">Leonora E. Long</name>
<affiliation wicri:level="1">
<nlm:affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Medical Sciences, University of New South Wales, Sydney, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Anderson, Paul" sort="Anderson, Paul" uniqKey="Anderson P" first="Paul" last="Anderson">Paul Anderson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Frank, Elisabeth" sort="Frank, Elisabeth" uniqKey="Frank E" first="Elisabeth" last="Frank">Elisabeth Frank</name>
<affiliation wicri:level="1">
<nlm:affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; University of Wollongong, Wollongong, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Schizophrenia Research Institute, Sydney, New South Wales, Australia; University of Wollongong, Wollongong, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Shaw, Alex" sort="Shaw, Alex" uniqKey="Shaw A" first="Alex" last="Shaw">Alex Shaw</name>
<affiliation wicri:level="1">
<nlm:affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Liu, Shijie" sort="Liu, Shijie" uniqKey="Liu S" first="Shijie" last="Liu">Shijie Liu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Huang, Xu Feng" sort="Huang, Xu Feng" uniqKey="Huang X" first="Xu-Feng" last="Huang">Xu-Feng Huang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; University of Wollongong, Wollongong, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Schizophrenia Research Institute, Sydney, New South Wales, Australia; University of Wollongong, Wollongong, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Pinault, Didier" sort="Pinault, Didier" uniqKey="Pinault D" first="Didier" last="Pinault">Didier Pinault</name>
<affiliation wicri:level="1">
<nlm:affiliation>INSERM U1114, psychopathologie cognitive et physiopathologie de la schizophrénie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U1114, psychopathologie cognitive et physiopathologie de la schizophrénie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Karl, Tim" sort="Karl, Tim" uniqKey="Karl T" first="Tim" last="Karl">Tim Karl</name>
<affiliation wicri:level="1">
<nlm:affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Medical Sciences, University of New South Wales, Sydney, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="O Brien, Terence J" sort="O Brien, Terence J" uniqKey="O Brien T" first="Terence J" last="O'Brien">Terence J. O'Brien</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Shannon Weickert, Cynthia" sort="Shannon Weickert, Cynthia" uniqKey="Shannon Weickert C" first="Cynthia" last="Shannon Weickert">Cynthia Shannon Weickert</name>
<affiliation wicri:level="1">
<nlm:affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Psychiatry, University of New South Wales, Sydney, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Jones, Nigel C" sort="Jones, Nigel C" uniqKey="Jones N" first="Nigel C" last="Jones">Nigel C. Jones</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25992564</idno>
<idno type="pmid">25992564</idno>
<idno type="doi">10.1371/journal.pone.0124114</idno>
<idno type="wicri:Area/PubMed/Corpus">002D52</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002D52</idno>
<idno type="wicri:Area/PubMed/Curation">002C77</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C77</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse.</title>
<author>
<name sortKey="Long, Leonora E" sort="Long, Leonora E" uniqKey="Long L" first="Leonora E" last="Long">Leonora E. Long</name>
<affiliation wicri:level="1">
<nlm:affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Medical Sciences, University of New South Wales, Sydney, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Anderson, Paul" sort="Anderson, Paul" uniqKey="Anderson P" first="Paul" last="Anderson">Paul Anderson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Frank, Elisabeth" sort="Frank, Elisabeth" uniqKey="Frank E" first="Elisabeth" last="Frank">Elisabeth Frank</name>
<affiliation wicri:level="1">
<nlm:affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; University of Wollongong, Wollongong, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Schizophrenia Research Institute, Sydney, New South Wales, Australia; University of Wollongong, Wollongong, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Shaw, Alex" sort="Shaw, Alex" uniqKey="Shaw A" first="Alex" last="Shaw">Alex Shaw</name>
<affiliation wicri:level="1">
<nlm:affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Liu, Shijie" sort="Liu, Shijie" uniqKey="Liu S" first="Shijie" last="Liu">Shijie Liu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Huang, Xu Feng" sort="Huang, Xu Feng" uniqKey="Huang X" first="Xu-Feng" last="Huang">Xu-Feng Huang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; University of Wollongong, Wollongong, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Schizophrenia Research Institute, Sydney, New South Wales, Australia; University of Wollongong, Wollongong, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Pinault, Didier" sort="Pinault, Didier" uniqKey="Pinault D" first="Didier" last="Pinault">Didier Pinault</name>
<affiliation wicri:level="1">
<nlm:affiliation>INSERM U1114, psychopathologie cognitive et physiopathologie de la schizophrénie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U1114, psychopathologie cognitive et physiopathologie de la schizophrénie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Karl, Tim" sort="Karl, Tim" uniqKey="Karl T" first="Tim" last="Karl">Tim Karl</name>
<affiliation wicri:level="1">
<nlm:affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Medical Sciences, University of New South Wales, Sydney, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="O Brien, Terence J" sort="O Brien, Terence J" uniqKey="O Brien T" first="Terence J" last="O'Brien">Terence J. O'Brien</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Shannon Weickert, Cynthia" sort="Shannon Weickert, Cynthia" uniqKey="Shannon Weickert C" first="Cynthia" last="Shannon Weickert">Cynthia Shannon Weickert</name>
<affiliation wicri:level="1">
<nlm:affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Psychiatry, University of New South Wales, Sydney, New South Wales</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Jones, Nigel C" sort="Jones, Nigel C" uniqKey="Jones N" first="Nigel C" last="Jones">Nigel C. Jones</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Brain (metabolism)</term>
<term>Brain (physiology)</term>
<term>Electroencephalography</term>
<term>Female</term>
<term>Heterozygote</term>
<term>Locomotion</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Mutant Strains</term>
<term>Neuregulin-1 (genetics)</term>
<term>Neuregulin-1 (physiology)</term>
<term>Phosphorylation</term>
<term>RNA, Messenger (genetics)</term>
<term>Receptors, N-Methyl-D-Aspartate (genetics)</term>
<term>Receptors, N-Methyl-D-Aspartate (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ARN messager (génétique)</term>
<term>Animaux</term>
<term>Encéphale (métabolisme)</term>
<term>Encéphale (physiologie)</term>
<term>Femelle</term>
<term>Hétérozygote</term>
<term>Locomotion</term>
<term>Mâle</term>
<term>Neuréguline-1 (génétique)</term>
<term>Neuréguline-1 (physiologie)</term>
<term>Phosphorylation</term>
<term>Récepteurs du N-méthyl-D-aspartate (génétique)</term>
<term>Récepteurs du N-méthyl-D-aspartate (métabolisme)</term>
<term>Souches mutantes de souris</term>
<term>Souris</term>
<term>Électroencéphalographie</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Neuregulin-1</term>
<term>RNA, Messenger</term>
<term>Receptors, N-Methyl-D-Aspartate</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>ARN messager</term>
<term>Neuréguline-1</term>
<term>Récepteurs du N-méthyl-D-aspartate</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Brain</term>
<term>Receptors, N-Methyl-D-Aspartate</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Encéphale</term>
<term>Récepteurs du N-méthyl-D-aspartate</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Encéphale</term>
<term>Neuréguline-1</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Brain</term>
<term>Neuregulin-1</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Electroencephalography</term>
<term>Female</term>
<term>Heterozygote</term>
<term>Locomotion</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Mutant Strains</term>
<term>Phosphorylation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Femelle</term>
<term>Hétérozygote</term>
<term>Locomotion</term>
<term>Mâle</term>
<term>Phosphorylation</term>
<term>Souches mutantes de souris</term>
<term>Souris</term>
<term>Électroencéphalographie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The Neuregulin 1 transmembrane domain heterozygous mutant (Nrg1 TM HET) mouse is used to investigate the role of Nrg1 in brain function and schizophrenia-like behavioural phenotypes. However, the molecular alterations in brain Nrg1 expression that underpin the behavioural observations have been assumed, but not directly determined. Here we comprehensively characterise mRNA Nrg1 transcripts throughout development of the Nrg1 TM HET mouse. In addition, we investigate the regulation of high-frequency (gamma) electrophysiological oscillations in this mutant mouse to associate molecular changes in Nrg1 with a schizophrenia-relevant neurophysiological profile.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">25992564</PMID>
<DateCreated>
<Year>2015</Year>
<Month>05</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2016</Year>
<Month>04</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>10</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse.</ArticleTitle>
<Pagination>
<MedlinePgn>e0124114</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0124114</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Neuregulin 1 transmembrane domain heterozygous mutant (Nrg1 TM HET) mouse is used to investigate the role of Nrg1 in brain function and schizophrenia-like behavioural phenotypes. However, the molecular alterations in brain Nrg1 expression that underpin the behavioural observations have been assumed, but not directly determined. Here we comprehensively characterise mRNA Nrg1 transcripts throughout development of the Nrg1 TM HET mouse. In addition, we investigate the regulation of high-frequency (gamma) electrophysiological oscillations in this mutant mouse to associate molecular changes in Nrg1 with a schizophrenia-relevant neurophysiological profile.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Using exonic probes spanning the cysteine-rich, epidermal growth factor (EGF)-like, transmembrane and intracellular domain encoding regions of Nrg1, mRNA levels were measured using qPCR in hippocampus and frontal cortex from male and female Nrg1 TM HET and wild type-like (WT) mice throughout development. We also performed electrophysiological recordings in adult mice and analysed gamma oscillatory at baseline, in responses to auditory stimuli and to ketamine.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In both hippocampus and cortex, Nrg1 TM HET mice show significantly reduced expression of the exon encoding the transmembrane domain of Nrg1 compared with WT, but unaltered mRNA expression encoding the extracellular bioactive EGF-like and the cysteine-rich (type III) domains, and development-specific and region-specific reductions in the mRNA encoding the intracellular domain. Hippocampal Nrg1 protein expression was not altered, but NMDA receptor NR2B subunit phosphorylation was lower in Nrg1 TM HET mice. We identified elevated ongoing and reduced sensory-evoked gamma power in Nrg1 TM HET mice.</AbstractText>
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">We found no evidence to support the claim that the Nrg1 TM HET mouse represents a simple haploinsufficient model. Further research is required to explore the possibility that mutation results in a gain of Nrg1 function.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Long</LastName>
<ForeName>Leonora E</ForeName>
<Initials>LE</Initials>
<AffiliationInfo>
<Affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anderson</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Frank</LastName>
<ForeName>Elisabeth</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; University of Wollongong, Wollongong, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shaw</LastName>
<ForeName>Alex</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Shijie</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Xu-Feng</ForeName>
<Initials>XF</Initials>
<AffiliationInfo>
<Affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; University of Wollongong, Wollongong, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pinault</LastName>
<ForeName>Didier</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>INSERM U1114, psychopathologie cognitive et physiopathologie de la schizophrénie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karl</LastName>
<ForeName>Tim</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>O'Brien</LastName>
<ForeName>Terence J</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shannon Weickert</LastName>
<ForeName>Cynthia</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Schizophrenia Research Institute, Sydney, New South Wales, Australia; Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jones</LastName>
<ForeName>Nigel C</ForeName>
<Initials>NC</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020890">Neuregulin-1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C490581">Nrg1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016194">Receptors, N-Methyl-D-Aspartate</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Front Hum Neurosci. 2012 Jan 13;5:190</RefSource>
<PMID Version="1">22319485</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Dis. 2010 Jul;39(1):116-25</RefSource>
<PMID Version="1">20153428</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2001 Feb 23;291(5508):1560-3</RefSource>
<PMID Version="1">11222864</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Brain Behav. 2007 Oct;6(7):677-87</RefSource>
<PMID Version="1">17309661</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Genet. 2004 Jan;41(1):31-4</RefSource>
<PMID Version="1">14729827</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):13118-23</RefSource>
<PMID Version="1">22822214</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Psychiatry. 2008 Feb;13(2):147-61</RefSource>
<PMID Version="1">17471287</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Harv Rev Psychiatry. 2010 May-Jun;18(3):173-89</RefSource>
<PMID Version="1">20415633</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2014 May 8;157(4):845-57</RefSource>
<PMID Version="1">24768692</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Schizophr Bull. 2012 Sep;38(5):950-7</RefSource>
<PMID Version="1">22355184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cogn Sci. 1999 Apr;3(4):151-162</RefSource>
<PMID Version="1">10322469</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2007 Jun 15;147(1):18-27</RefSource>
<PMID Version="1">17512671</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Brain Res. 2011 Oct 1;223(2):336-41</RefSource>
<PMID Version="1">21605597</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Psychiatry. 2004 Mar;9(3):299-307</RefSource>
<PMID Version="1">14569272</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Neuropsychopharmacol. 2013 Feb;16(1):163-75</RefSource>
<PMID Version="1">22226049</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychopharmacology (Berl). 2010 Aug;211(3):277-89</RefSource>
<PMID Version="1">20571781</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1993 Mar 12;72(5):801-15</RefSource>
<PMID Version="1">8453670</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2011 Oct 27;478(7370):519-23</RefSource>
<PMID Version="1">22031444</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Front Cell Neurosci. 2013 Feb 26;7:18</RefSource>
<PMID Version="1">23447438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 1995 Jul;130(1):127-35</RefSource>
<PMID Version="1">7540614</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Brain Res. 2012 Jan 1;226(1):218-23</RefSource>
<PMID Version="1">21944941</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 2003 Dec;13(12):1369-74</RefSource>
<PMID Version="1">14615302</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(4):e34129</RefSource>
<PMID Version="1">22509273</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Neuropsychopharmacol. 2011 Jun;14(5):631-43</RefSource>
<PMID Version="1">20701826</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2006 Dec;9(12):1520-5</RefSource>
<PMID Version="1">17099708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Struct Funct. 2016 Mar;221(2):1067-81</RefSource>
<PMID Version="1">25515311</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Neurosci. 1998 May;11(1-2):77-91</RefSource>
<PMID Version="1">9608535</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Psychiatry. 2003 May;8(5):485-7</RefSource>
<PMID Version="1">12808428</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2004 Oct 14;44(2):251-61</RefSource>
<PMID Version="1">15473965</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2012 Sep 12;32(37):12657-72</RefSource>
<PMID Version="1">22972991</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Psychiatry. 2014 Jul 15;76(2):120-7</RefSource>
<PMID Version="1">24210810</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychopharmacology (Berl). 2007 Jun;192(3):325-36</RefSource>
<PMID Version="1">17333138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Crit Rev Neurobiol. 2000;14(1):1-21</RefSource>
<PMID Version="1">11253953</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2007 Feb;18(2):380-93</RefSource>
<PMID Version="1">17108327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 2009 Mar;19(3):612-8</RefSource>
<PMID Version="1">18632742</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2009;4(8):e6755</RefSource>
<PMID Version="1">19707548</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Front Cell Neurosci. 2013 Feb 26;7:15</RefSource>
<PMID Version="1">23447498</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychopharmacology. 2008 Sep;33(10):2442-55</RefSource>
<PMID Version="1">18059437</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Rep. 2014 Aug 21;8(4):1130-45</RefSource>
<PMID Version="1">25131210</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 Jan 26;276(4):2841-51</RefSource>
<PMID Version="1">11042203</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci Methods. 2004 Mar 15;134(1):9-21</RefSource>
<PMID Version="1">15102499</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2007 Nov 23;149(4):861-70</RefSource>
<PMID Version="1">17905522</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Biol. 2003 Jun 23;161(6):1133-41</RefSource>
<PMID Version="1">12821646</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hum Genet. 2003 Jan;72(1):83-7</RefSource>
<PMID Version="1">12478479</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2001 Jan 5;276(1):693-9</RefSource>
<PMID Version="1">11024032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Cells. 2007 Mar;12(3):329-43</RefSource>
<PMID Version="1">17352738</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Med Genomics. 2009 May 20;2:28</RefSource>
<PMID Version="1">19457239</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2013 Apr;16(4):499-506</RefSource>
<PMID Version="1">23416452</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6747-52</RefSource>
<PMID Version="1">16618933</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurosci. 2010 Feb;11(2):100-13</RefSource>
<PMID Version="1">20087360</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2007 Mar 14;27(11):2858-65</RefSource>
<PMID Version="1">17360907</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2000 May;26(2):443-55</RefSource>
<PMID Version="1">10839362</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 1992 Apr 3;69(1):205-16</RefSource>
<PMID Version="1">1348215</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2006 Oct 27;314(5799):664-6</RefSource>
<PMID Version="1">16990514</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2007 Apr 25;27(17):4519-29</RefSource>
<PMID Version="1">17460065</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Schizophr Res. 2008 Mar;100(1-3):270-80</RefSource>
<PMID Version="1">18243664</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2003 Jul 16;23(15):6315-26</RefSource>
<PMID Version="1">12867516</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Dis. 2012 Apr;46(1):93-100</RefSource>
<PMID Version="1">22245663</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Neuropsychopharmacol. 2009 Nov;12(10):1383-93</RefSource>
<PMID Version="1">19400983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Transl Psychiatry. 2012;2:e104</RefSource>
<PMID Version="1">22832904</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2010 Apr 29;464(7293):1376-80</RefSource>
<PMID Version="1">20393464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2007 May 24;54(4):599-610</RefSource>
<PMID Version="1">17521572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hum Genet. 2002 Oct;71(4):877-92</RefSource>
<PMID Version="1">12145742</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Psychiatry. 2009;9:71</RefSource>
<PMID Version="1">19917116</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2010 Oct 27;170(3):800-7</RefSource>
<PMID Version="1">20678553</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2012 Nov;36(10):3407-19</RefSource>
<PMID Version="1">22928838</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 1995 Aug 11;270(32):19188-96</RefSource>
<PMID Version="1">7642587</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2012 Feb 15;590(4):715-24</RefSource>
<PMID Version="1">22219337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 1993 Mar 25;362(6418):312-8</RefSource>
<PMID Version="1">8096067</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2005 Sep 15;47(6):845-57</RefSource>
<PMID Version="1">16157279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Neurosci. 2003 Sep;26(9):489-95</RefSource>
<PMID Version="1">12948660</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2011 Jun 8;31(23):8491-501</RefSource>
<PMID Version="1">21653853</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2009 Sep 30;29(39):12255-64</RefSource>
<PMID Version="1">19793984</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Development. 1997 Sep;124(18):3575-86</RefSource>
<PMID Version="1">9342050</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 2012 Jul;22(7):1520-9</RefSource>
<PMID Version="1">21878485</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1992 May 22;256(5060):1205-10</RefSource>
<PMID Version="1">1350381</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3596-601</RefSource>
<PMID Version="1">10725395</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2012 Feb;15(2):267-73</RefSource>
<PMID Version="1">22158511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2007 May 24;54(4):583-97</RefSource>
<PMID Version="1">17521571</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2013 Sep 18;79(6):1152-68</RefSource>
<PMID Version="1">24050403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Psychiatry. 2006 Sep 15;60(6):548-53</RefSource>
<PMID Version="1">16730337</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004569" MajorTopicYN="N">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006579" MajorTopicYN="Y">Heterozygote</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008124" MajorTopicYN="N">Locomotion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008817" MajorTopicYN="N">Mice, Mutant Strains</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020890" MajorTopicYN="N">Neuregulin-1</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016194" MajorTopicYN="N">Receptors, N-Methyl-D-Aspartate</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4437646</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>02</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>03</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>5</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>5</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>4</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25992564</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0124114</ArticleId>
<ArticleId IdType="pii">PONE-D-14-07289</ArticleId>
<ArticleId IdType="pmc">PMC4437646</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C77 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002C77 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:25992564
   |texte=   Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:25992564" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024